Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

   141,861,898      
Direct Value   $82,119,756    

Indirect Value

   $12,961,771,173      
Total Shares   142,789,105      
Total Value   $13,043,890,929      


Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634 Incyte Corp $32,589,847 Seagen Inc $49,182,531 Synageva BioPharma Corp $0 Genomic Health Inc $18,271 Biocryst Pharmaceuticals Inc $312,474 Neurogene $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    36   
    6    

     Stock price went up :
    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 50 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KOD Kodiak Sciences Inc. Director   –       •       •   2022-05-16 4 B $5.71 $697,839 I/I 122,100 14,843,809 2.25 %
INCY Incyte Corp Director   –       •       •   2010-08-09 4 S $14.08 $1,724,784 I/I (122,467) 3,364,533 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2006-02-28 4 S $19.90 $2,465,505 I/I (122,854) 2,150,377 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-02-21 4 B $5.90 $745,509 I/I 123,330 6,771,259 1.5 -
SGEN Seagen Inc Director   –       •       •   2008-03-14 4 B $8.06 $997,429 I/I 123,528 7,813,945 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2006-02-27 4 S $21.58 $2,692,747 I/I (123,987) 2,273,231 -
GEVA Synageva BioPharma Corp Director   –       •       •   2006-10-02 4 D $0.00 $0 I/I (126,415) 160,420 0 -
BCRX Biocryst Pharmaceuticals ... 10% Owner   –       –       •   2009-05-29 4 S $4.12 $524,991 I/I (126,448) 3,984,905 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-04-17 4 S $15.43 $1,977,056 I/I (128,066) 3,952,047 0 -
SGEN Seagen Inc Director   –       •       •   2011-09-06 4 B $17.00 $2,206,641 I/I 129,187 14,776,080 2.25 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2009-02-05 4 S $8.11 $1,062,228 I/I (130,463) 2,285,840 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-04-13 4 S $15.30 $1,997,341 I/I (130,472) 1,856,449 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2009-05-08 4 B $5.92 $779,933 I/I 131,661 6,389,807 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2011-11-07 4 B $26.20 $3,474,033 I/I 132,371 6,276,241 2.25 -
INCY Incyte Corp Director   –       •       •   2022-02-18 4 B $68.37 $9,096,550 I/I 133,032 32,947,370 2.25 %
KOD Kodiak Sciences Inc. Director   –       •       •   2022-01-21 4 B $56.57 $7,577,571 I/I 133,414 13,660,140 2.25 %
GEVA Synageva BioPharma Corp Director   –       •       •   2011-11-02 4 A $0.00 $0 I/I 135,462 143,962 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2007-11-08 4 B $7.43 $1,025,104 I/I 137,894 2,035,060 1.5 -
ALTH Allos Therapeutics Inc 10% Owner   –       –       •   2008-01-08 4 B $7.21 $994,457 I/I 137,895 6,219,693 1.5 -
GHDX Genomic Health Inc Director   –       •       •   2012-05-15 4 B $33.11 $4,772,474 I/I 140,000 242,888 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2007-05-22 4 B $16.67 $2,382,705 I/I 142,938 1,017,895 2.25 -
INCY Incyte Corp Director   –       •       •   2011-12-07 4 B $13.21 $1,915,214 I/I 144,903 11,484,023 2.25 -
ADLR Adolor Corp 10% Owner   –       –       •   2010-04-28 4 B $1.82 $278,647 I/I 146,944 5,676,679 1.5 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-06-11 4 OE $1.03 $152,174 I/I 147,313 777,506 0 -
SGEN Seagen Inc Director   –       •       •   2007-02-14 4 S $8.72 $1,307,390 I/I (149,930) 4,957 0 -
  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50  51   52   53   54   55   56      
  Page 50 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us